BBWI241122P28000
- 0.08
- -0.04-33.33%
Bath & Body Works Newsroom
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating, Announces Target Price $35
Citi Maintains Bath & Body Works(BBWI.US) With Hold Rating, Maintains Target Price $35
Analysts Conflicted on These Consumer Cyclical Names: Lucid Group (LCID), Global-e Online (GLBE) and Bath & Body Works (BBWI)
Bath & Body Works Is Maintained at Outperform by Telsey Advisory Group
Bath & Body Works Analyst Ratings
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $48
Morgan Stanley Adjusts Price Target on Bath & Body Works to $48 From $51, Maintains Overweight Rating
Barclays Downgrades Bath & Body Works(BBWI.US) to Sell Rating, Cuts Target Price to $28
Bath & Body Works Analyst Ratings
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Cuts Target Price to $32
BofA Securities Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating
Bath & Body Works Analyst Ratings
Baird Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
Telsey Advisory Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $42
BMO Capital Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $50
Buy Rating Affirmed for Bath & Body Works Amid Strategic Management Changes and Solid Financial Outlook
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $51
Morgan Stanley Maintains Overweight on Bath & Body Works, Lowers Price Target to $51